Reaction
Skin Operation reporting signals
As of the last recalculation, Skin Operation appears in 306 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RISANKIZUMAB-RZAA (PRR 28.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Risankizumab-Rzaa | 31 | 28.6 | 28.6 |
| Bimekizumab | 6 | 19.5 | 19.5 |